These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 614548)

  • 1. [Effects of beta adrenergic block on arterial hypertension and the electrocardiographic signs of myocardium damage].
    Bisteni A
    Prensa Med Mex; 1977; 42(11-12):516-21. PubMed ID: 614548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].
    Gysling E; de Wurstemberger B
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1797-8. PubMed ID: 4456598
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 6. [Central effects of beta adrenergic receptor blockaders, obsidan and trasicor, in arterial hypertension].
    Kukes VG; Kazarian AB; Sozinov VN; Paramonov LV; Kniazev RP
    Sov Med; 1989; (8):61-3. PubMed ID: 2814668
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.
    Pollavini G; Comi D; Grillo C; Lombardo M; Mantero O; Minetti L; Selvini A; Suppa G
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):451-5. PubMed ID: 6490228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
    Contino A
    G Clin Med; 1979 May; 60(5):402-8. PubMed ID: 488590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
    Gambini G; Pizzuti C; Valori C
    Clin Ter; 1988 Feb; 124(3):203-10. PubMed ID: 2974332
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oxprenolol on blood pressure, pulmonary ventilatory function and myocardial contractility in hypertensive patients.
    Schlesinger Z; Barzilay J
    Isr J Med Sci; 1980 Jun; 16(6):420-5. PubMed ID: 7399873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 15. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension update for the 1980s.
    Lowenthal DT; Swartz CD
    Prim Care; 1985 Mar; 12(1):101-15. PubMed ID: 2859624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
    Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of oxprenolol on the plasma renin activity in essential arterial hypertension].
    Cospite M; Lo Presti T; Ferrara F; Mineo R
    Boll Soc Ital Cardiol; 1977; 22(3):335-9. PubMed ID: 617279
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.